Nursing Elites

1. What is a surgical procedure to create an opening in the windpipe to assist with breathing?

• A. Tracheostomy
• B. Lobectomy
• C. Thoracotomy
• D. Pleurodesis

Correct answer: A

Rationale: Tracheostomy is the correct answer. It is a surgical procedure to create an opening in the windpipe (trachea) to assist with breathing. This procedure is commonly used for patients who require long-term ventilation support. Choice B, Lobectomy, involves the removal of a lobe of the lung and is not related to creating an opening in the windpipe. Choice C, Thoracotomy, is a surgical incision into the chest wall and is not specifically related to creating an opening in the windpipe. Choice D, Pleurodesis, is a procedure to treat recurrent pleural effusions by causing the pleural layers to stick together, and it is not related to creating an opening in the windpipe.

2. What is the condition where the lungs become filled with fluid, often due to heart failure, making it difficult to breathe?

• A. Pulmonary edema
• B. Pleural effusion
• C. Pulmonary hypertension
• D. Pneumothorax

Correct answer: A

Rationale: Pulmonary edema is the correct answer. It occurs when fluid fills the lungs, usually due to heart failure, leading to breathing difficulties. Pleural effusion is the accumulation of fluid around the lungs, not inside. Pulmonary hypertension is high blood pressure in the arteries of the lungs, and pneumothorax is the presence of air between the lung and chest wall.

3. The client on warfarin has an INR of 1.2. What is the nurse’s priority action?

• A. Increase the dose of warfarin
• B. Administer vitamin K
• C. Monitor for signs of bleeding
• D. Hold the next dose and notify the healthcare provider

Correct answer: A

Rationale: The correct answer is to increase the dose of warfarin. An INR of 1.2 is below the therapeutic range for a client on warfarin, indicating that the dose is subtherapeutic. The priority action in this situation is to adjust the dose to achieve the target therapeutic INR range (usually 2-3) to prevent thromboembolic events. Administering vitamin K is not necessary as the INR is low, and there are no signs of bleeding. Monitoring for signs of bleeding is important but not the priority in this case since the INR is subtherapeutic. Holding the next dose and notifying the healthcare provider would delay the intervention needed to adjust the dose and achieve the therapeutic range.

4. What is a condition where the blood supply to the brain is interrupted or reduced, preventing brain tissue from getting oxygen and nutrients?

• A. Stroke
• B. Transient ischemic attack (TIA)
• C. Myocardial infarction
• D. Angina

Correct answer: A

Rationale: A stroke is the correct answer. A stroke occurs when the blood supply to part of the brain is interrupted or reduced, leading to a lack of oxygen and nutrients to the brain tissue, causing brain damage. Choices B, C, and D are incorrect because a transient ischemic attack (TIA) is a temporary blockage of blood flow to the brain with no lasting damage, myocardial infarction is a heart attack due to blockage of blood flow to the heart muscle, and angina is chest pain caused by reduced blood flow to the heart.

5. What is a type of heart disease that involves the thickening or stiffening of the heart muscle, reducing its ability to pump blood?

• A. Hypertrophic cardiomyopathy
• B. Dilated cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Arrhythmia

Correct answer: A

Rationale: Hypertrophic cardiomyopathy is a type of heart disease characterized by the thickening or stiffening of the heart muscle, leading to a reduced ability to pump blood. This condition is different from dilated cardiomyopathy (choice B), which involves the enlargement and weakening of the heart chambers. Restrictive cardiomyopathy (choice C) is characterized by the stiffening of the heart muscle, affecting its ability to fill with blood properly. Arrhythmia (choice D) refers to abnormal heart rhythms and is not specifically related to thickening or stiffening of the heart muscle, as seen in hypertrophic cardiomyopathy.

Similar Questions